Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 3.32 USD -6.74% Market Closed
Market Cap: 207.2m USD
Have any thoughts about
Fulcrum Therapeutics Inc?
Write Note

Fulcrum Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fulcrum Therapeutics Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Fulcrum Therapeutics Inc
NASDAQ:FULC
Total Equity
$273.8m
CAGR 3-Years
35%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Equity
$70.2B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$17.1B
CAGR 3-Years
-23%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$87.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Total Equity
$44.5B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Total Equity
$14.2B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
-2%

See Also

What is Fulcrum Therapeutics Inc's Total Equity?
Total Equity
273.8m USD

Based on the financial report for Jun 30, 2024, Fulcrum Therapeutics Inc's Total Equity amounts to 273.8m USD.

What is Fulcrum Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 5Y
39%

Over the last year, the Total Equity growth was -1%. The average annual Total Equity growth rates for Fulcrum Therapeutics Inc have been 35% over the past three years , 39% over the past five years .

Back to Top